James Momtazee, Director at Roivant Sciences, holds 109.81K shares in Roivant Sciences (Ticker: ROIV), holds 99.07K shares in BridgeBio Pharma (Ticker: BBIO), holds 3.52K shares in PRA Health Sciences (Ticker: PRAH).
James Momtazee latest transaction was an Uninformative Buy of ―.
What was James Momtazee's most profitable transaction?
James Momtazee’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is James Momtazee's role in Roivant Sciences?
James Momtazee's role in Roivant Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.